Reuters logo
BRIEF-Atyr Pharma reports issuance of U.S. patent that extends patent protection of physiocrines
March 15, 2017 / 10:44 AM / 6 months ago

BRIEF-Atyr Pharma reports issuance of U.S. patent that extends patent protection of physiocrines

March 15 (Reuters) - Atyr Pharma Inc:

* Atyr Pharma announces issuance of U.S. patent that extends patent protection of physiocrines derived from 20 out of 20 human TRNA synthetases Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below